Friday, March 05, 2010 8:41:19 PM
LaBranche & Co Inc. Announces Final Results of Its Cash Tender Offer
LaBranche & Co Inc. (NYSE:LAB) (the “Company”) today announced the final results of its previously announced offer to purchase for cash (the “Tender Offer”) up to 15 million shares of its common stock. The Tender Offer expired on March 1, 2010, at 5:00 p.m., New York City time (the “Expiration Date”).
The depositary for the Tender Offer, BNY Mellon Shareowner Services, has advised the Company that 8,539,667 million shares of its common stock (including 282,342 shares tendered through guaranteed delivery procedures) were validly tendered and not validly withdrawn pursuant to the Tender Offer, representing approximately 16.6% of its outstanding common stock as of January 28, 2010. All shares that were validly tendered and not validly withdrawn have been accepted for purchase.
The information agent for the Tender Offer is Morrow & Co., LLC. Questions and requests for information about the Tender Offer should be directed to Morrow & Co. at (800) 607-0088.
THIS PRESS RELEASE IS FOR INFORMATIONAL PURPOSES ONLY AND DOES NOT CONSTITUTE AN OFFER TO BUY OR THE SOLICITATION OF AN OFFER TO SELL SHARES OF LABRANCHE & CO INC.’S COMMON STOCK.
The Company is the parent of LaBranche Structured Holdings, Inc., whose subsidiaries are market-makers in options, exchange-traded funds and futures on various exchanges domestically and internationally, and LaBranche Financial Services, LLC, which provides securities execution, fixed income and brokerage services to institutional investors.
Certain statements contained in this release, including without limitation, statements containing the words “believes,” “intends,” “expects,” “anticipates,” and words of similar import constitute forward-looking statements. Readers are cautioned that any such forward-looking statements are not guarantees of future performance, and since such statements involve risks and uncertainties, the actual results and performance of the Company and the industry may turn out to be materially different from the results expressed or implied by such forward-looking statements. Given these uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements. The Company also disclaims any obligation to update its view of any such risks or uncertainties or to publicly announce the result of any revisions to the forward-looking statements made in this release. Notwithstanding anything in this release, the safe harbor protections of the Private Securities Litigation Reform Act of 1995 do not apply to statements made in connection with a tender offer.
Recent LAB News
- Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable Growth • GlobeNewswire Inc. • 04/25/2024 12:01:00 PM
- Standard BioTools Announces Conference Call and Webcast for First Quarter 2024 Financial Results on May 8, 2024 • GlobeNewswire Inc. • 04/25/2024 12:00:00 PM
- Standard BioTools Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the boundaries of Tissue Imaging • GlobeNewswire Inc. • 04/08/2024 12:00:00 PM
- Standard BioTools Announces Multi-Year Strategic Engagement with Bristol Myers Squibb for Use of the SomaScan® Platform for Translational Medicine Research • GlobeNewswire Inc. • 04/03/2024 08:01:13 PM
- Standard BioTools Announces Exchange of All Outstanding Series B Convertible Preferred Stock for Common Stock • GlobeNewswire Inc. • 03/18/2024 12:12:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 12:20:18 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 09:05:55 PM
- Standard BioTools Reports Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 02/28/2024 09:01:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/26/2024 09:15:31 PM
- Standard BioTools and Next Gen Diagnostics Announce Partnership to Provide Complete Automation of Low-Cost Pathogen Sequencing • GlobeNewswire Inc. • 02/26/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 10:01:56 PM
- Standard BioTools to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 02/22/2024 09:05:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 08:32:04 PM
- Standard BioTools Announces Conference Call and Webcast for Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024 • GlobeNewswire Inc. • 02/14/2024 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/08/2024 05:15:32 AM
- Standard BioTools and Navignostics Announce Collaboration Agreement to Advance Imaging Capabilities in Personalized Medicine • GlobeNewswire Inc. • 02/07/2024 01:30:35 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/02/2024 09:49:35 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 01/19/2024 10:07:18 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 01/19/2024 10:05:28 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/19/2024 10:03:57 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/19/2024 09:48:03 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 01/19/2024 09:33:24 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 01/12/2024 07:04:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/10/2024 01:51:32 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM